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Infections pose multiple challenges to healthcare systems and contribute to higher mortality, morbidity and escalating cost. Clinicians must regularly make rapid decisions on empiri-
cal antibiotic treatment of infectious syndromes without know-
ing the causative pathogen (or pathogens) or whether they are 
drug-susceptible or drug-resistant. In some cases, this is directly 
linked to poor outcomes; in the case of septic shock, the risk of 
death increases by an estimated 10% with every 60 min of delay in 
initiating effective treatment1.
The molecular epidemiology of infectious disease allows us to 
identify high-risk pathogens and to determine their patterns of 
spread on the basis of their genetics or (increasingly) genomics. 
Conventionally, such studies, including outbreak investigations and 
characterization of previously untested resistant strains, have been 
conducted in retrospect, but this has been changing with the avail-
ability of increasingly inexpensive sequencing technologies2,3. The 
wealth of data generated by genomics are promising, but introduces 
a challenge because while many features of a sequence are correlated 
with the phenotype of interest, few are causative.
Prescription, however, has long been informed by correlative 
features when causative ones are difficult to measure; for example, 
whether the same syndrome or pathogen occurring in other patients 
from the same clinical environment have responded to a particular 
antibiotic. This has also been observed at the genetic level as a result 
of genetic linkage between resistance elements and the rest of the 
genome. An example is given by the pneumococcus S. pneumoniae. 
The Centers for Disease Control and Prevention (CDC) has rated 
the threat level of drug-resistant pneumococcus as “serious”4. While 
resistance arises in pneumococci through a variety of mechanisms, 
approximately 90% of the variance in the minimal inhibitory con-
centration (MIC) for antibiotics of different classes can be explained 
by the loci determining the strain type5, even though none of these 
loci themselves causes resistance. Thus, in the overwhelming major-
ity of cases, resistance and susceptibility can be inferred from coarse 
strain typing based on the population structure. This population 
structure could be leveraged to offer an alternative approach to 
detecting resistance whereby rather than detecting high-risk genes, 
we identify high-risk strains. While many approaches have been 
developed to identify whether a pathogen carries mutations or 
genes known to confer resistance6–21 (see ref. 22 for a comprehensive 
review), this is not equivalent to the clinical question of whether the 
pathogen is susceptible.
We present a method called genomic neighbour typing that 
can bring molecular epidemiology closer to the bedside and pro-
vide information relevant to treatment at a much earlier stage. Our 
method takes sequences generated from a sample in real time and 
matches them to a database of genomes to identify the closest rela-
tives. Because closely related isolates usually have similar proper-
ties, this yields an informed heuristic regarding the phenotype of 
the pathogen. We demonstrate this by identifying drug-resistant 
and drug-susceptible clones for both S. pneumoniae (the pneu-
mococcus) and N. gonorrhoeae (the gonococcus) within minutes 
after the start of sequencing using Oxford Nanopore Technology 
(ONT). The method has many potential applications depending on 
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the specific pathogen and the quality of the databases available for 
matching, which we discuss together with its limitations.
Results
Resistance is associated with clones in S. pneumoniae and 
N. gonorrhoeae. To quantify the association of clones with antibi-
otic resistance of the pathogens S. pneumoniae and N. gonorrhoeae, 
we constructed optimal predictors of resistance from bacterial lin-
eages and measured the associated area under the receiver operating 
characteristic curve (AUC) (Supplementary Fig. 1). First, we applied 
the method to 616 pneumococcal genomes from a carriage study 
of children in Massachusetts, USA23,24. Second, we used 1,102 clini-
cal gonococcal isolates collected from 2000 to 2013 by the CDC’s 
Gonococcal Isolate Surveillance Project25. In both cases, the datas-
ets comprised draft genome assemblies from Illumina HiSeq reads, 
resistance data and lineages inferred from sequence clusters com-
puted using Bayesian analysis of population structure26. Lineages 
of S. pneumoniae were predictive for benzylpenicillin, ceftriaxone, 
trimethoprim–sulfamethoxazole, erythromycin and tetracycline 
resistance, with AUC values ranging from 0.90 to 0.97 (Supplementary 
Fig. 2), which is consistent with previous works5. For N. gonorrhoeae, 
ciprofloxacin, ceftriaxone and cefixime attained comparably large 
AUC values (from 0.93 to 0.98), whereas azithromycin demon-
strated a lower association (AUC value of 0.80) (Supplementary 
Fig. 3), which is as previously observed25.
Rapid identification of nearest known relatives from sequenc-
ing reads. Based on the observed associations, we developed an 
approach that we term genomic neighbour typing to predict the 
phenotype from sequencing data. Genomic neighbour typing is a 
two-step algorithm that first compares a provided sample to a data-
base of reference genomes with a known phylogeny and phenotype, 
and then predicts the probable phenotype of the sample based on 
the best hits (nearest neighbours) and their matching quality. We 
apply this here to the detection of drug resistance.
To implement genomic neighbour typing, we developed software 
called resistance-associated sequence elements (RASE) (Fig. 1). 
RASE takes a stream of nanopore reads and compares their k-mer 
content to references using a modified version of ProPhyle27,28, 
which is a metagenomic classifier that implements a fast and mem-
ory-efficient exact coloured de Bruijn graph data structure29 using 
a Burrows–Wheeler transform (BWT) index30 (Methods). Using 
ProPhyle RASE identifies which references are the most similar 
to the read and increases their similarity weights (this approach 
was inspired by but differs from other similar approaches such as 
Kraken31 and Kallisto32). These weights are cumulative scores that 
capture sample-to-reference similarity; they are set to zero at the 
beginning and are increased on the fly as sequencing proceeds 
according to the ‘information content’ of each read (Methods). 
Generally speaking, longer reads, such as those covering multiple 
accessory genes, tend to be specific and have high scores, whereas 
short reads or reads from the core genome are found in many lin-
eages, tend to be nonspecific and have low scores. Weights serve as 
a proxy to the inverted genetic distance between the sample and 
the references.
Resistance or susceptibility is predicted in two steps based on 
the computed weights, the population structure and the reference 
phenotypes. First, RASE identifies the lineage of the best-matching 
reference genome and estimates the confidence of lineage assign-
ment by comparing the two best-matching lineages to compute a 
‘lineage score’ (Methods). Subsequently, RASE identifies the best 
match within that lineage and predicts resistance from the near-
est resistant and susceptible neighbours. A comparison of their 
weights provides a ‘susceptibility score’, which quantifies the risk of 
resistance (Methods). When the weights are too similar, the confi-
dence of the call is considered low; this happens when resistant and 
susceptible strains are insufficiently genetically distinct, which is 
often the case for resistance that has recently emerged in evolution-
ary history (Methods). The ability to pinpoint the closest relatives 
in the database offers further resolution, even in the case where the 
resistance phenotype varies within a lineage.
Results of RASE are reported in real time as the best match in the 
database, together with susceptibility scores to the antibiotics being 
tested and a proportion of matching k-mers for quality control. As 
the run progresses, the scores fluctuate and eventually stabilize (an 
example is shown in Fig. 2).
RASE databases for hundreds of S. pneumoniae and N. gonorrhoeae 
strains. We constructed RASE databases for S. pneumoniae and 
N. gonorrhoeae from the same data as described above (Methods). 
We assigned each pneumococcal and gonococcal strains to antibi-
otic-specific resistance categories using the European Committee 
on Antimicrobial Susceptibility Testing (EUCAST) breakpoints33 
and the CDC Gonococcal Isolate Surveillance Project (GISP) 
breakpoints34, respectively (Methods). Where MIC data were 
unavailable or insufficiently specific, we estimated the probable 
resistance phenotype using ancestral state reconstruction (Methods; 
Supplementary Note 1; Extended Data Figs. 3 and 4). To verify the 
results, we tested eight pneumococcal isolates for which resistance 
phenotypes were not originally available (Methods), and the mea-
sured MICs by microdilution matched the expected phenotypes 
(shown in bold in Table 1). We constructed the ProPhyle k-mer 
indexes using a k-mer length that was optimized to minimize pre-
diction delays (k = 18; Methods). The obtained pneumococcal and 
gonococcal RASE databases occupy 321 MB and 242 MB of RAM 
(×4.3 and ×12, respectively, compression rate) and can be further 
compressed for transmission to 47 MB and 32 MB (×29 and ×90, 
respectively, compression rate), respectively (Extended Data Fig. 1). 
This would allow RASE to be used on portable devices and its data-
bases to be easily transmitted to the point of care over links with a 
limited bandwidth.
RASE identifies strains in the database within minutes. We 
first examined two pneumococcal isolates that were used to build 
the RASE database (100% sensitivity and 100% specificity, n = 10; 
Table 1a) to test whether RASE can function in ideal circumstances. 
In the case of a fully susceptible isolate (SP01), the correct lin-
eage and sequenced strain were identified within 1 min and 7 min, 
respectively. A multidrug-resistant isolate (SP02) was predicted 
even faster, with both lineage and the sequenced strain correctly 
detected and stabilized within 1 min. To compare our method to 
gene-based approaches for detecting resistance22, we evaluated how 
long it took for resistance genes to be sequenced on the device. We 
observed that at least 25 min would be needed for single copies to be 
detected (Supplementary Note 2; Extended Data Fig. 2).
We then performed a similar evaluation with five gonococcal iso-
lates from the database (57% sensitivity and 100% specificity, n = 20; 
Table 2a); however, here, we selected more complicated cases. First, 
we tested a susceptible isolate (GC01), for which RASE identified 
the correct strain and antibiogram within 3 min of sequencing. We 
then sequenced an isolate (GC02) with an uncommon mechanism 
of cephalosporin resistance that has recently emerged35. Under 
such circumstances, the resistant strain and its susceptible neigh-
bours tend to be genetically very similar, which could confound 
our analysis. However, RASE was still able to identify the correct 
resistance phenotypes in 9 min, with the delay due to the difficulty 
in distinguishing between the close relatives, which was reflected 
by a susceptibility score in the low-confidence range (Methods). 
This was repeated in further experiments with the same isolate 
(GC03), which consistently reported low confidence in the resis-
tance phenotype (Methods). This feature of our approach intends 
to alert the operators to indicate that further testing is necessary. 
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In this experiment, RASE also resolved sample mislabelling 
(Supplementary Note 3). For a multidrug-resistant isolate (GC04), 
RASE predictions stabilized within 2 min, but incorrectly predicted 
susceptibility to ceftriaxone. A subsequent analysis revealed that the 
ceftriaxone MIC of the sample was equal to the CDC GISP break-
point (0.125 μg ml–1), whereas the best match in the database had an 
MIC of 0.062 μg ml–1, within a single doubling dilution. We further 
found that RASE performed well even with extremely poor data 
and low-quality reads (for example, GC05; Supplementary Note 4). 
We also evaluated how genomic neighbour typing would perform 
if RASE used Kraken31 instead of ProPhyle27,28, and results are pre-
sented in Supplementary Note 5.
RASE identifies the closest relative of previously untested 
isolates. We next examined four pneumococcal isolates (89% sensi-
tivity and 100% specificity, n = 20; Table 1b) for which the serotype 
and limited antibiogram and lineage data were known. We com-
pared the following three characteristics of the sample to assess our 
performance: the serotype, the sequence type as determined by mul-
tilocus sequence typing (MLST) and the antibiograms (benzylpeni-
cillin, ceftriaxone, trimethoprim–sulfamethoxazole, erythromycin 
and tetracycline resistance according to the EUCAST breakpoints33).
In all cases, the closest relative was identified within 5 min, even 
if the correct MLST sequence type was absent from the RASE data-
base (an example is shown in Fig. 2). The two samples from the 23F 
clone (SP03 and SP06) were correctly called as being closely related 
to the Tennessee 23F-4 clone identified by the Pneumococcal 
Molecular Epidemiology Network, a clone strongly associated with 
macrolide resistance36. Consistent with this, the two samples were 
indeed resistant to erythromycin. However, the Tennessee 23F-4 
clone was absent from the Massachusetts sample, with the best 
match being a comparatively distantly related strain that was resis-
tant to penicillin, but susceptible to erythromycin. This illustrates 
the importance of a relevant database.
We evaluated RASE with 14 clinical gonococcal isolates from the 
RaDAR-Go project37 (Switzerland, 2015–2016) (93% sensitivity and 
100% specificity, n = 56; Table 2b). These isolates were previously 
sequenced using nanopore and have full antibiograms available38. 
The 55 out of 56 correct calls indicate the strength of the genomic 
neighbour typing in a clinical setting. The only incorrect call (sus-
ceptibility to azithromycin for GC15) was marked as being low con-
fidence on the basis of a poor susceptibility score. It should be noted 
that the ranges for what is considered low confidence could vary 
among settings and pathogens, but can be empirically determined 
and modified by users. In this case, our results suggest that informa-
tive results can be obtained even when using a database from one 
region (the United States) to predict phenotypes in another region 
(Europe). However, this may not be the case for all pathogens.
Inference is still informative but lower quality on highly diver-
gent lineages. As noted above, an important precondition of 
genomic neighbour typing is a comprehensive and relevant ref-
erence database. To evaluate the performance of RASE in a set-
ting with an incomplete database, we used the gonococcal WHO 
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(Non-susc.) calls, respectively. The dashed lines mark selected time points (1 min, 5 min and the end of sequencing (2,700 min)). b–d, Similarity rank 
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(World Health Organization) 2016 reference strain collection39. 
This includes a global collection of 14 diverse isolates from Europe, 
Asia, North America and Australia, collected over two decades and 
exhibiting phenotypes ranging from pan-susceptibility to multi-
drug resistance, and as such, the GISP database is expected to be 
non-representative in this study. The WHO strains are available 
from the National Collection of Type Cultures, and were previously 
sequenced using nanopore38 and genetically and phenotypically 
characterized39. Surprisingly, RASE correctly identified all MLST-
identified sequence types represented in the database, and in seven 
cases it provided fully correct resistance phenotypes (67% sensitiv-
ity and 91% specificity, n = 56; Supplementary Table 1). In six out 
of seven cases where the complete resistance profile was not recov-
ered, the closest relatives were correctly identified, but were geneti-
cally divergent from the query isolates (Supplementary Note 6). In 
one case, the errors were due to a misidentification of the closest 
relatives by ProPhyle. Therefore, most prediction errors could be 
addressed with a more comprehensive database.
RASE can identify resistance in pneumococcus from sputum 
metagenomic samples. Because bacterial culture and phenotyp-
ing via agar-dilution, Etest or disk diffusion introduces significant 
delays in resistance profiling, direct metagenomic sequencing of 
clinical samples would be preferable for point-of-care use. We there-
fore analysed metagenomic nanopore data from sputum samples 
obtained from patients suffering from lower respiratory tract infec-
tions40 (UK, 2017), selecting six samples from the study that were 
already known to contain S. pneumoniae (75% sensitivity and 100% 
specificity, n = 16; Table 1c).
One sample (SP10) contained DNA from multiple bacterial spe-
cies. However, within 5 min, the sequence was identified to belong 
to the Swedish 15A-25 clone (ST63), which is also known to be 
associated with resistance phenotypes including macrolides and 
tetracyclines41. This sample was confirmed to be resistant to eryth-
romycin and to clindamycin, tetracycline and oxacillin according 
to the EUCAST breakpoints33. The original report of the Swedish 
15A-25 clone did not report resistance to penicillin antibiotics41, 
which has subsequently emerged in this lineage. However, our 
database correctly identified the risk of penicillin resistance in this 
sample. The metagenomes SP11 and SP12 contained an estimated 
>20% reads that matched S. pneumoniae, and their serotypes were 
identified to be 15A and 153, respectively. The susceptibility scores 
of the best matches were fully consistent with the resistance profiles 
found in the samples, with the exception of tetracycline resistance 
in SP12 due to an incomplete database (Supplementary Note 7). The 
last remaining samples, SP07–SP09, contained <5% unambiguously 
pneumococcal reads. Despite the low proportions, all predicted phe-
notypes were concordant with phenotypic tests, with the exception 
of SP07, which matched the same strain as SP12 (discussed above).
Discussion
This paper presents a method, which we termed genomic neighbour 
typing, to pinpoint the closest relatives of a query genome within 
a suitable database and then to infer the phenotypic properties 
Table 1 | Predicted phenotypes of S. pneumoniae for database isolates (a), non-database isolates (b) and metagenomes (c)
(a) Database isolates
Sample Lineage 
confidently 
detected
Matched 
k-mers 
(%)
Serotype Antibiogram 
CRO
Antibiogram 
eRY
Antibiogram 
PeN
Antibiogram 
SXT
Antibiogram 
TeT
MLST 
match
CC 
match
Actual Best 
match
Actual Best 
match
Actual Best 
match
Actual Best 
match
Actual Best 
match
Actual Best 
match
SP01 Yes 16 11D 11Da S Sa S Sa S Sa S Sa S(1) S(1)a Yesa Yesa
SP02 Yes 9.6 19A 19Aa R Ra R Ra R Ra R Ra R(2) R(2)a Yesa Yesa
(b) Non-database isolates
Sample Lineage 
confidently 
detected
Matched 
k-mers 
(%)
Serotype Antibiogram  
CRO
Antibiogram  
eRY
Antibiogram  
PeN
Antibiogram  
SXT
Antibiogram 
TeT
MLST 
match
CC 
match
Actual Best 
match
Actual Best 
match
Actual Best 
match
Actual Best 
match
Actual Best 
match
Actual Best 
match
SP03 Yes 3.1 23F 23Fa R Ra R S(3)b R Ra R Ra S Sa OoDc Yesa
SP04 Yes 12 19A 19Aa R Ra R Ra R Ra R Ra R R(4)a OoDc Yesa
SP05 No 1.8 19F 19Fa R Ra R Ra,d R Ra R Ra,d R Ra,d OoDc Yesa
SP06 Yes 8.3 23F 23Fa R Ra R S(3)b R Ra R Ra S Sa OoDc Yesa
(c) Metagenomes
Sample Lineage 
confidently 
detected
SP (%) Matched  
k-mers (%)
Antibiogram eRY Antibiogram PeN Antibiogram TeT
Actual Best match Actual Best match Actual Best match
SP07 No 2.3 0.2 NA Sc S Sa R S(5)b
SP08 No 2.5 0.9 S Sa S Sa,d S S(6)a
SP09 No 4.0 1.2 NA Sc S Sa S S(7)a
SP10 Yes 21 5.2 R Ra R Ra R R(8)a
SP11 Yes 70 14 R Ra R Ra R R(8)a
SP12 Yes 86 17 S Sa S Sa R S(5)b
The table displays actual and predicted resistance phenotypes (where ‘S’ represents susceptible and ‘R’ represents non-susceptible) for individual experiments and information on the match of the 
predicted MLST-identified sequence type and the clonal complex (CC). Resistance categories in bold were inferred using ancestral reconstruction and were confirmed using phenotypic testing  
(see Methods and Supplementary Table 2). Metagenomic samples were sorted by the estimated fraction of S. pneumoniae reads (SP). aCorrect prediction. bIncorrect prediction. cCannot be evaluated.  
dLow confidence call. OoD, out of database; (n), identity of a retested sample; NA, not available. For definitions of antibiotics see Fig. 2.
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of the query strain on the basis of the reported properties of its 
relatives. At present, the precise lineage of a bacterial pathogen is 
often determined after most important clinical decisions have been 
made. However, incorporating genomic neighbour typing at an ear-
lier stage offers a way of leveraging bacterial population structure 
to gain information on resistance and susceptibility, and to guide 
antimicrobial therapy. The results from the metagenomic samples 
suggest that it is possible to apply this approach directly to clinical 
samples, and the success with both S. pneumoniae and N. gonor-
rhoeae indicates that it may have wide application.
The two pathogens studied here present contrasting features; the 
gonococcus is Gram-negative, harbours plasmids and has a strik-
ingly uniform core genome, while the pneumococcus is Gram-
positive, does not contain plasmids and is diverse in both its core 
and accessory genome. Both exhibit high rates of homologous 
recombination, which is expected to both spread chromosomally 
encoded resistance elements and to scramble the phylogenetic sig-
nal that we use to identify the lineages. Despite these differences and 
the large degree of recombination, our approach performs well with 
both pathogens, with some differences that indicate opportunities 
and limitations of the application.
The initial identification of the closest relative was consistently 
more robust in the pneumococcus than the gonococcus, which is 
a result of the former having more k-mers that are specific to an 
individual lineage, thus reflecting greater sequence diversity. As a 
consequence of the much lower diversity in gonococcus, when mul-
tiple closely related genomes are present in the database, RASE fluc-
tuated between them, even though it correctly identified the region 
of the phylogeny. If these genomes vary in their resistance profile, 
this is properly reflected in an uncertain susceptibility score that 
indicates caution and further investigation are merited (for exam-
ple, GC03).
As in all inference, the principle limitation of genomic neigh-
bour typing is the representativeness of the database. While we 
have made use of relatively small samples from limited geographi-
cal areas to demonstrate proof of principle, in practice, there are 
multiple examples of large genomic databases generated by public 
health agencies, which could be combined with metadata on resis-
tance for genomic neighbour typing. Such databases could, if neces-
sary, be supplemented with local sampling. The relevant question 
for our approach therefore becomes whether the database contains 
a sufficiently high proportion of strains that will be encountered 
in the clinic and whether the resistance data are correct. Further 
work is required to determine the optimal structure and contents 
of databases for each application, but we emphasize the range of 
pathogens that appear to show promise for this approach. These 
include Escherichia coli, in which data on MLST-identified sequence 
types supplemented with epidemiological information consistently 
Table 2 | Predicted phenotypes of N. gonorrhoeae for database isolates (a) and non-database isolates (b)
(a) Database isolates
Sample Lineage 
confidently 
detected
Matched  
k-mers (%)
Antibiogram AZM Antibiogram CFM Antibiogram CiP Antibiogram CRO MLST 
matchActual Best 
match
Actual Best 
match
Actual Best 
match
Actual Best 
match
GC01 Yes 27 S Sa S Sa S Sa S Sa Yesa
GC02 Yes 27 S Sa R Ra,c S Sa R Ra,c Yesa
GC03 Yes 33 S Sa R Sb,c S Sa R Sb,c Yesa
GC04 Yes 21 S Sa R Ra R Ra R Sb Yesa
GC05 Yes 7 R Ra S Sa S Sa S Sa Yesa
(b) Non-database isolates
Sample Lineage  
confidently  
detected
Matched 
k-mers 
(%)
Antibiogram AZM Antibiogram CFM Antibiogram CiP Antibiogram 
CRO
Actual Best 
match
Actual Best 
match
Actual Best 
match
Actual Best 
match
GC06 Yes 19 S Sa R Ra R Ra S Sa
GC07 No 20 S Sa S Sa R Ra S Sa
GC08 No 19 S Sa S Sa R Ra S Sa
GC09 No 18 S Sa S Sa S Sa S Sa
GC10 No 20 S Sa S Sa R Ra S Sa
GC11 No 20 S Sa S Sa R Ra S Sa
GC12 No 20 S Sa S Sa R Ra S Sa
GC13 Yes 20 S Sa S Sa R Ra S Sa
GC14 Yes 19 S Sa S Sa R Ra S Sa
GC15 Yes 19 R Sb,c S Sa S Sa S Sa
GC16 No 18 S Sa S Sa,c R Ra S Sa,c
GC17 No 19 S Sa S Sa,c R Ra S Sa,c
GC18 No 20 S Sa S Sa R Ra S Sa
GC19 Yes 18 S Sa S Sa R Ra S Sa
The table displays actual and predicted resistance phenotypes (S and R) for individual experiments and information on the match of the predicted MLST-identified sequence type. aCorrect prediction. 
bIncorrect prediction. cLow-confidence call. AZM, azithromycin; CFM, cefixime; CIP, ciprofloxacin.
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produced AUC values in excess of 0.90 for multiple antibiotics42, 
which suggests that there is great potential for neighbour typing 
to offer excellent resolution that is superior to MLST. However, we 
anticipate that genomic neighbour typing may be less suitable in 
cases when there is little within-species genomic variation (mean-
ing it is hard to identify the nearest neighbour) or when resistance 
rapidly emerges on independent and diverse genomic backgrounds 
(meaning resistance is poorly correlated with those backgrounds) 
(Supplementary Note 8).
In cases where the infectious agent is unknown, this problem is 
significantly more challenging. k-mers from one pathogen can match 
others and produce false predictions, and so the choice of the cor-
rect database for prediction is key. Doing this will probably require 
a two-step solution in which the reads are first passed through a 
metagenomic classifier such as Centrifuge43 or MetaMaps44, which 
would be used to select the correct RASE database on which to 
make a resistance call.
Another limitation is the time required for sample preparation, 
which currently includes human DNA depletion, DNA isolation 
and library preparation, thereby taking a total of 4 h. However, this 
is a rapidly evolving area of technology and automated rapid library 
preparation kits are already in development45. Further advances in 
this space, in particular for the preparation of metagenomic sam-
ples, will be required to bring the method closer to the bedside.
We have demonstrated that effectively predicting resistance and 
susceptibility from sequencing data does not require knowledge 
of causal resistance determinants. In fact, neighbour typing only 
requires that the phenotype be sufficiently strongly associated with 
the population structure to make reliable predictions.
A key advantage of this approach is that it requires very little 
genomic data, thus it is not limited by high error rates or low cover-
age. In particular, it is not attempting to define the exact genome 
sequence of the sample being tested, but merely which lineage it 
comes from. As a result, even when a small fraction of k-mers in 
the read are informative in matching to the RASE database, this is 
sufficient to call the lineage. This has the benefit of being faster than 
gene detection by virtue of the informative k-mers being distributed 
throughout the genome, and so more likely to appear in the first few 
reads sequenced by the nanopore. Therefore, the approach we pres-
ent here can be seen as an application of compressed sensing; that is, 
by measuring a sparse signal distributed broadly across our data, we 
can identify it with comparatively few error-tolerant measurements.
Genomic neighbour typing can also be used to detect other phe-
notypes that are sufficiently tightly linked to a phylogeny, such as 
virulence. Further applications may include rapid outbreak inves-
tigations, as the closely related isolates involved in the outbreak 
would all be predicted to match to the same strain in the RASE 
database. The approach also lends itself to enhanced surveillance, 
including in the field; the 2014–2016 Ebola outbreak in West Africa, 
for example, saw MinION devices used in remote locations without 
advanced healthcare facilities2. Finally, at present, empirical treat-
ment decisions are made within successive ‘windows’46, in which 
increasing information becomes available, from initial Gram stain 
to full phenotypic characterization. The information from genomic 
neighbour typing is a natural complement to this process and has 
the potential to improve therapy long before it would become 
clinically apparent that the patient is not responding or before phe-
notypic susceptibility data were available. The combination of high-
quality RASE databases with genomic neighbour typing offers an 
alternative forward-looking model for diagnostics and surveillance, 
with wide applications for the improved clinical management of 
infectious disease.
Methods
Overview. RASE uses rapid approximate k-mer-based matching of long sequencing 
reads against a database of strains to predict resistance via neighbour typing. The 
database contains a highly compressed exact k-mer index, a representation of the 
tree population structure and metadata such as lineage, resistance profiles, MLST-
based sequence type and serotype. The RASE prediction pipeline iterates over reads 
from the nanopore sequencer and provides real-time predictions of lineage and 
resistance or susceptibility (Fig. 1).
Resistance profiles. For all antibiotics, RASE associates individual strains with 
a resistance category: ‘susceptible’ (S) or ‘non-susceptible’ (R). First, intervals of 
possible MIC values are extracted using regular expressions from the available textual 
antibiograms. For instance, ‘≥4’, ‘2’ and ‘NA’ would be translated to the intervals 
[4, + ∞), [2, 2] and [0, + ∞), respectively. Then the acquired intervals are compared to 
the antibiotic-specific breakpoints. If a given breakpoint is above or below the interval, 
susceptibility or non-susceptibility is reported, respectively. However, no category 
can be assigned at this step if the breakpoint lies within the extracted interval, an 
antibiogram is entirely missing, it is insufficiently specific or its parsing failed. Finally, 
missing categories are inferred using ancestral state reconstruction on the associated 
phylogenetic tree while maximizing parsimony (that is, minimizing the number 
of nodes switching its resistance category; Extended Data Figs. 3 and 4). When the 
solution for a node is not unique, non-susceptibility is assigned.
Genomic neighbour typing using nanopore sequencing. All reference strains in 
the database are associated with similarity weights that are set to zero at the start 
of the run. Each time a new read is read from the stream, k-mer-based matching is 
applied to identify the strains with the maximum number of matching k-mers (see 
below). Such strains are nearest neighbours to the read in the database according to 
the 1/(‘number of matched k-mers’) pseudodistance.
The weights of the nearest neighbours are then increased according to the 
information content of the read, calculated as the number of matched k-mers 
divided by the number of nearest neighbours. Reads that do not match (that is, 
0 matching k-mers in the database) are not used in subsequent analysis. The 
computed matches are also used for updating the k-mer score (KS), which is the 
proportion of matched k-mers in all reads. The KS helps to assess whether a sample 
is truly matching the database and whether predicting resistance for the database 
species makes sense.
The obtained weights serve as a proxy to the inverted genetic distance and 
are used as a basis for the subsequent predictions of the lineage and the antibiotic 
resistance and susceptibility.
Predicting lineage. A lineage is predicted as the lineage of the best-matching 
reference strain; that is, the one with the largest weight. The quality of lineage 
prediction is further quantified using a lineage score (LS), calculated as LS = 2 f/
(f + t) – 1, where f and t denote the weights of the best matches in the first 
(‘predicted’) and in the second best (‘alternative’) lineage, respectively. The values 
of the LS can range from 0.0 to 1.0 with the following special cases: LS = 1.0 means 
that all reads were perfectly matching the predicted lineage, whereas LS = 0.0 
means that the predicted and alternative lineages were matched equally well.
The LS is used to measure how well a sample matches the identified lineage. 
If the LS is higher than a specified threshold (0.6 in default settings), the call is 
considered successful. If the score is lower than this, the sample cannot be securely 
assigned to a lineage, and this should draw the attention of the operators. Note that 
custom RASE databases may require a recalibration of the threshold.
Predicting resistance and susceptibility. Resistance or susceptibility is 
independently predicted for individual antibiotics based on the weights of 
the strains that belong to the predicted lineage. These are used to calculate a 
susceptibility score, which is further interpreted by comparing to predefined 
thresholds.
The susceptibility score (SS) is calculated as SS = s/(s + r), where s and r denote 
the weights of the best-matching susceptible and best-matching non-susceptible 
strains within the lineage, respectively. The values of the SS can range from 0.0 to 
1.0 with the following special cases: SS = 0.0 and SS = 1.0 mean that all reads match 
only resistant or susceptible strains in the lineage, respectively. In practice, this 
happens only if the lineage is entirely associated with resistance or susceptibility. 
SS = 0.5 means that the best matching resistant and susceptible strains are matched 
equally well. As follows from the score definition, if SS is greater than 0.5, then the 
best-matching strain is susceptible, otherwise it is non-susceptible.
The SS is used for predicting resistance or susceptibility and for evaluating 
the confidence of the prediction. If the SS is greater than 0.5, susceptibility to the 
antibiotic is reported, otherwise non-susceptibility is reported. Hence, resistance 
is predicted as the resistance of the best match. However, when the SS is within the 
[0.4, 0.6] range, it is considered a low-confidence call, and as such it should draw 
the attention of the operators; this usually indicates that resistance or susceptibility 
has recently emerged in the evolutionary history, and genomic neighbour typing 
may not be able to confidently distinguish between these similar, but phenotypically 
distinct, strains. Note that the thresholds above might require a further recalibration 
based on the specific database, antibiotics and application of RASE.
S. pneumoniae RASE database. The S. pneumoniae RASE database was 
constructed using the EUCAST breakpoints33 for the following antibiotics (mg l–1): 
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ceftriaxone (0.25), erythromycin (0.25), benzylpenicillin (0.06), trimethoprim-
sulfamethoxazole (1.00) and tetracycline (1.00). While we used the above values in 
the present work, others may be readily defined and the database rapidly updated. 
This is especially useful in cases where breakpoints may vary depending on the 
site of infection (as is the case with pneumococcal meningitis and otitis media, for 
which lower MICs are considered to be resistant33).
The draft assemblies were downloaded from the SRA FTP server using 
the accession codes provided in table 1 in ref. 24. The phylogenetic tree was 
downloaded from DataDryad (accession no.: https://doi.org/10.5061/dryad.t55gq). 
The pneumococcal ProPhyle index was constructed with the k-mer size of k = 18.
The obtained S. pneumoniae RASE database, including the source code and 
data, is available at https://github.com/c2-d2/rase-db-spneumoniae-sparc.
N. gonorrhoeae RASE database. The N. gonorrhoeae RASE database was 
constructed with the CDC GISP breakpoints34 for the following antibiotics (mg l–1): 
azithromycin (2.0), cefixime (0.25), ciprofloxacin (1.0) and ceftriaxone (0.125). 
Before applying the breakpoints, azithromycin MICs for strains collected before 
2005 were doubled to correct for the known inconsistencies of the phenotyping 
protocol, which were due to a change in formulation of the commercial media47.
The draft assemblies and the phylogenetic tree were downloaded from Zenodo 
(accession no.: https://doi.org/10.5281/zenodo.2618836). The following three 
prevalent types of plasmids48 were downloaded from GenBank, localized in the 
GISP database using BLAST49 and removed from the dataset: the cryptic plasmid 
pJD1 (GenBank accession no.: NC_001377.1), the beta-lactamase plasmid pJD4 
(GenBank accession no.: NC_002098.1) and the conjugative plasmid pEP5289 
(GenBank accession no.: GU479466.1). The gonococcal ProPhyle index was 
constructed with the k-mer size of k = 18.
The obtained N. gonorrhoeae RASE database, including the source code and 
data, is available at https://github.com/c2-d2/rase-db-ngonorrhoeae-gisp.
k-mer-based matching. Reads were matched against the RASE databases using 
the ProPhyle classifier27,28 (commit b55e026) and its ProPhex component50,51. The 
ProPhyle index stores k-mers of all strains in a highly compressed form, reducing 
the required memory footprint. In the database construction phase, the k-mers 
of the strains are first propagated along the phylogenetic tree and then greedily 
assembled to simplitigs52. The obtained simplitigs are then placed into a single text 
file, for which a BWT index is constructed30.
In the course of sequencing, each read is decomposed into overlapping k-mers. 
The k-mers are then searched in the BWT index by ProPhex using BWT search 
using a sliding window50. For every k-mer, the obtained matches are translated back 
on the tree. This provides a list of nodes whose descending leaves are the strains 
containing that k-mer. Finally, strains with maximum number of matched k-mers 
are identified for each read and reported in the SAM/BAM format53.
Optimizing the k-mer length. The k-mer length is the main parameter of the 
classification. First, the subword complexity function54 of pneumococcus was 
calculated using JellyFish55 (v.2.2.10) (Extended Data Fig. 5). Then, based on the 
characteristics of the function and the k-mer range supported by ProPhyle, the 
possible range of k was determined as previously described17,32. For these k-mer 
lengths, RASE indexes were constructed and their performance evaluated using 
the RASE prediction pipeline and selected experiments. While RASE showed 
robustness to k-mer length in terms of final predictions, prediction delays differed 
(Extended Data Fig. 6). Based on the obtained timing data, we set the k-mer length 
to k = 18.
Comparison to Kraken. For each RASE database, a fake NCBI taxonomy was 
generated from the database tree. Then, a library was built using Kraken31 (v.1.1.1, 
default parameters) from the same FASTA files as used for building the RASE 
database. Finally, Kraken databases were constructed for both k = 18 and k = 31.
The obtained Kraken databases were used to classify reads from individual 
experiments. The obtained Kraken assignments were subsequently converted using 
an ad hoc Python script to RASE-BAM (a subset of the BAM format53 used by 
RASE). Finally, RASE prediction was applied on the BAM files, with the use of the 
RASE database metadata, and the results compared with the results of the standard 
RASE with ProPhyle.
Measuring time. To determine how RASE works with nanopore data generated 
in real time, the timestamps of individual reads were extracted using regular 
expressions from the read names. These were then used for sorting the base-called 
nanopore reads by time. When the RASE pipeline was applied, the timestamps 
were used for expressing the predictions as a function of time. The times of 
ProPhyle assignments were also compared to the original timestamps to ensure 
that the prediction pipeline was not slower than sequencing.
When timestamps of sequencing reads were not available (that is, the 
gonococcal WHO data and clinical samples), RASE estimated the progress in 
time from the number of processed base pairs. This was done by dividing the 
cumulative base-pair count by the typical nanopore flow, which we had previously 
estimated from SP01 as 1.43 Mbps per s. However, such an estimated progress 
is indicative only, as it does not follow the true order of reads in the course of 
sequencing. As the nanopore signal quality tends to decrease over time (see the 
decrease of KS in Fig. 2 after t = 15 mins), the randomized read order provides 
results of lower quality than true real-time sequencing.
Lower time estimates on resistance gene detection. A complete genome of the 
multidrug-resistant SP02 isolate was assembled from the nanopore reads using 
CANU56 (v.1.5, default parameters). Before the assembly step, reads were filtered 
using SAMsift57 based on the matching quality with the pneumococcal RASE 
database: only reads at least 1,000-bp long with at least 10% 18-mers shared with 
some of the reference draft assemblies were used. The obtained assembly was 
further corrected using Pilon58 (v.1.2, default parameters) and Illumina reads from 
the same isolate (taxid 1QJAP in the SPARC dataset24) mapped to the nanopore 
assembly using BWA-MEM59 (v.0.7.17, default parameters) and sorted using 
SAMtools53.
The obtained assembly was searched for resistance-causing genes using the 
online CARD tool16 (as of 1 Aug 2018). All of the original nanopore reads were 
then mapped using Minimap2 (v.2.11, with ‘-x map-ont’)60 to the corrected 
assembly, and resistance genes in the reads were identified using BEDtools–
intersect61 (v.2.27.1, with ‘-F 95’). Timestamps of the resistance-informative reads 
were extracted and associated with the genes. Only reads longer than 2 kbp were 
used in the analysis.
Evaluation of the N. gonorrhoeae WHO samples. To evaluate the predictions 
of the WHO samples, we inferred a phylogenetic tree from a dataset comprising 
both the GISP isolates and the WHO isolates. First, reads were downloaded for 
the GISP isolates (NCBI BioProject no.: PRJEB2999 and PRJEB7904) and for the 
WHO isolates F–P (NCBI BioProject no.: PRJEB4024). For the WHO isolates 
U–Z, read data were simulated from the finished de novo assemblies (NCBI 
BioProject no.: PRJEB14020) using Art-Illumina62 (v.2.5.1). Reads were mapped 
to the NCCP11945 reference genome (GenBank accession no.: CP001050.1) using 
BWA-MEM59 (v.0.7.17) and deduplicated using Picard63 (v.2.8.0). Pilon58 (v.1.16, 
with ‘–mindepth 10–minmq 20’) was used to call variants and further filtered 
to include only ‘pass’ sites, and sites where the alternative allele was supported 
with AF > 0.9. Gubbins64 (v.2.3.4) with RAxML65 (v.8.2.10) were run on the 
aligned pseudogenomes to generate the final recombination-corrected phylogeny 
(Supplementary Data 1).
The closest relatives identified by RASE were verified using the obtained tree. 
For every WHO isolate, the obtained RASE prediction was compared to the closest 
GISP isolate on the tree.
Library preparation. For isolates SP01–SP06, cultures were grown in Todd–Hewitt 
medium with 0.5% yeast extract (THY; Becton Dickinson) at 37 °C in 5% CO2 for 
24 h. High-molecular-weight (>1 μg) genomic DNA was extracted and purified 
from cultures using a DNeasy Blood and Tissue kit (Qiagen). DNA concentration 
was measured using a Qubit fluorometer (Invitrogen). Library preparation was 
performed using an ONT 1D ligation sequencing kit (SQK LSK108).
For isolates SP07–SP12, library preparation was performed using an ONT 
Rapid Low-Input Barcoding kit (SQK-RLB001), with saponin-based host DNA 
depletion used for reducing the proportion of human reads. More details can be 
found in the original manuscript40.
For isolates GC01–GC05, cultures were grown on Chocolate-Agar media (that 
is, Difco GC base media containing 1% IsoVitaleX (Becton Dickinson) and 1% 
Remel Hemoglobin (Thermo Fisher Scientific)) at 37 °C in 5% CO2 for 20 h. For 
GC01–GC04, genomic DNA was extracted and purified from cultures using a 
PureLink Genomic DNA mini kit (Thermo Fisher Scientific). For GC05, DNA was 
extracted using the phenol–chloroform method66. Genomic DNA was extracted 
and purified from cultures using the PureLink Genomic DNA mini kit (Thermo 
Fisher Scientific). DNA concentration was measured using a Qubit fluorometer 
(Invitrogen). Library preparation was performed using the ONT 1D ligation 
sequencing kit (SQK-LSK109).
MinION sequencing. Sequencing was performed on a MinION MK1 device 
using R9.4/FLO-MIN106 flow cells according to the manufacturer’s instructions. 
For experiments SP01–SP06, base calling was performed using ONT Metrichor 
(v.1.6.11 (SP01), v.1.7.3 (SP02), v.1.7.14 (SP03–SP06)) simultaneously with 
sequencing, and all reads passing Metrichor quality check were used in the further 
analysis. For experiments SP07–SP12, the ONT MinKNOW software (v.1.4-1.13.1) 
was used to collect raw sequencing data, and ONT Albacore (v.1.2.2-2.1.10) was 
used for local base-calling of the raw data after sequencing runs were completed. 
For experiments GC01–GC05, ONT MinKNOW software was used to collect raw 
sequencing data, and ONT Albacore (v.2.3.4) was used for local base-calling.
Testing resistance phenotype. Additional retesting of SPARC isolates was done 
using microdilution. Organism suspensions were prepared from overnight growths 
on blood agar plates to the density of a 0.5 McFarland standard. This organism 
suspension was then diluted to provide a final inoculum of 105 to 106 colony-
forming units per ml. Microdilution trays were prepared according to the NCCLS 
methodology with cation-adjusted Mueller–Hinton broth (Sigma-Aldrich) 
supplemented with 5% lysed horse blood (Hemostat Laboratories)67,68. Penicillin 
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(TRC Canada) and chloramphenicol (USB) concentrations ranged from 0.016 
to 16 μg ml–1. Erythromycin (Enzo Life Sciences), tetracycline (Sigma-Aldrich) 
and trimethoprim–sulfamethoxazole (MP Biomedicals) concentrations ranged 
from 0.0625 to 64 μg ml–1. Ceftriaxone (Sigma-Aldrich) concentrations ranged 
from 0.007 to 8 μg ml–1. The microdilution trays were incubated in ambient air at 
35 °C for 24 h. The MICs were then visually read and breakpoints applied. A list of 
individual microdilution measurements and the obtained resistance categories is 
provided in Supplementary Table 2.
Resistance of streptococcus in the metagenomic samples (SP07–SP12) was 
determined by agar diffusion using the EUCAST methodology and breakpoints33. 
First, the inoculated agar plates were incubated at 37 °C overnight and then 
examined for growth, with the potential for reincubation up to 48 h. Then, the 
samples were screened to oxacillin: if the zone diameter r was >20 mm, the 
isolate was considered to be sensitive to benzylpenicillin, otherwise a full MIC 
measurement to benzylpenicillin was done. Finally, the isolate was screened for 
resistance to tetracycline (r ≥ 25 mm for sensitive, r < 22 mm for resistant) and 
erythromycin (r ≥ 22 mm for sensitive, r < 19 mm for resistant); when the isolate 
showed intermediate resistance, a full MIC measurement was done.
Results for all tested samples, isolates and metagenomes are summarized in 
Supplementary Table 3.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Data availability
The analyses in the paper were performed using the following RASE databases: 
“N. gonorrhoeae GISP USA v1.4” (available at https://github.com/c2-d2/rase-db-
ngonorrhoeae-gisp/releases) and “S. pneumoniae SPARC USA v1.3” (available 
at https://github.com/c2-d2/rase-db-spneumoniae-sparc/releases). Nanopore 
reads for all experiments from this study have been deposited in Zenodo with 
the accession code 10.5281/zenodo.3346055; for the metagenomic experiments 
(SP07–SP12), only the filtered datasets were made publicly available (that is, after 
removing the remaining human reads in silico to comply with privacy policies). 
Additional supplementary materials are available at https://github.com/c2-d2/rase-
supplement.
Code availability
RASE was developed using Python, GNU Make, GNU Parallel69, Snakemake70  
and the ETE 3 (ref. 71) and PySam53 libraries, and was based on ProPhyle27,28 
(commit b55e026). Bioconda72 was used to ensure reproducibility of the  
software environments. The core RASE package and RASE documentation are 
available at https://github.com/c2-d2/rase. The prediction pipeline is available at 
https://github.com/c2-d2/rase-pipeline. Codes for constructing the S. pneumoniae 
and N. gonorrhoeae RASE databases are available at https://github.com/c2-d2/rase-
db-spneumoniae-sparc and https://github.com/c2-d2/rase-db-ngonorrhoeae-gisp, 
respectively. A skeleton for creating new databases is available from https://github.
com/c2-d2/rase-db-skeleton.
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Extended Data Fig. 1 | Size and memory footprint of the S. pneumoniae and N. gonorrhoeae RASe databases. The graph compares the size of the ProPhyle 
RASE index to the size of the original sequences: original draft assemblies (seq−fa), original draft assemblies compressed using gzip (seq−fagz), memory 
footprint of ProPhyle with the RASE index (ind−mem), and size of the ProPhyle RASE index compressed for transmission (ind−transm).
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Extended Data Fig. 2 | Timeline of resistance genes. Number of occurrences of individual resistance genes in reads of SP02, as a function of time for the 
first hour of nanopore sequencing.
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Extended Data Fig. 3 | Ancestral state reconstruction of resistance categories in the S. pneumoniae RASe database. Each panel corresponds to a single 
antibiotic and displays the database phylogenetic tree, colored according to the reconstructed resistance categories for the antibiotic (blue, green, red, 
violet correspond to ‘susceptible’, ‘unknown – inferred susceptible’, ‘non-susceptible’, ‘unknown – inferred non-susceptible’, respectively).
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Extended Data Fig. 4 | Ancestral state reconstruction of resistance categories in the N. gonorrhoeae RASe database. Each panel corresponds to a single 
antibiotic and displays the database phylogenetic tree, colored according to the reconstructed resistance categories for the antibiotic (blue, green, red, 
violet correspond to ‘susceptible’, ‘unknown – inferred susceptible’, ‘non-susceptible’, ‘unknown – inferred non-susceptible’, respectively).
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Extended Data Fig. 5 | Subword complexity of pneumococcus. The plot depicts the number of canonical k-mers as a function of k for S. pneumoniae ATCC 
700669 (GenBank accession: ‘NC_011900.1’) and for a random DNA text containing all possible k-mers. For k<10, the pneumococcus k-mer composition 
is similar to the one of random text. For k>14, the k-mer sets are almost saturated and the complexity grows very slowly. Since the genome length is finite 
and bacterial chromosomes are circular, the function attains its maximum at the genome size (2,221,315 in this case). The highlighted region corresponds 
to the range of values of k, which are suitable for use in RASE.
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Extended Data Fig. 6 | Delays in prediction based on the k-mer length. The plot displays delays in prediction as a function of the used k-mer length, for 
selected experiments and all possible k-mer lengths. Each horizontal panel displays times required for stabilization of one of the three predictions: the 
lineage, the alternative lineage, and the closest strain. Every column within a panel corresponds to a single k-mer length. When the required time exceeded 
1 hour, the point is displayed at the top. Experiments where lineage could not be identified are plotted in red. The highlighted column corresponds to the  
k-mer length used for constructing the RASE databases in this paper.
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